MedPath

Effects of Sucrose Added Blind to the Diet Over Eight Weeks on Body Mass and Weight in Men

Not Applicable
Completed
Conditions
Overweight
Interventions
Dietary Supplement: Sucrose
Registration Number
NCT04804397
Lead Sponsor
University of Hull
Brief Summary

Background: Sugar intake, especially in liquid, correlates with obesity. Yet, whether it is a special cause of obesity is less clear. Few experimental studies exist.

Aim: To replicate the investigators' previous 4 week experiments on women with men over 8 weeks to ascertain if: they gain weight given sucrose soft drinks; mood is affected; energy intake is affected.

Participants: 80 men BMI 25-35, aged 30-55. Procedure: After a week of baseline, over eight weeks single blind 40 men received soft drinks containing sucrose (1650 KJ, 97g carbohydrate per day), 40 received control drinks. A three-day food diary with mood ratings and activity levels was completed during baseline and weeks 1, 4 and 8 of the experiment. Body mass was recorded weekly with other anthropometric measures.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
80
Inclusion Criteria
  • BMI 25-35
Exclusion Criteria
  • Diabetes,
  • other health problems,
  • medication,
  • dislike of soft drinks

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
AspartameSucroseAspartame: 1l aspartame sweetened soft drink per day for 8 weeks as 4 25cl drinks
SucroseSucroseSucrose: 1l sucrose sweetened soft drink per day for 8 weeks (1650 KJ, 97g carbohydrate per day) as 4 25cl drinks
Primary Outcome Measures
NameTimeMethod
Body MassEight Weeks

Do participants gain weight?

Secondary Outcome Measures
NameTimeMethod
Mood assessed using 10 rating scalesEight Weeks

Are there changes in rated mood during sucrose supplementation?

Daily energy intake assessed by free-living unweighed food diaryEight Weeks

Do participants eat less to compensate for added sucrose?

© Copyright 2025. All Rights Reserved by MedPath